Designing a novel freeze-stable tetanus vaccine
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Poster
- By: MOSHARRAF, Mitra (HTD Biosystems Inc., Pleasanton, ca, United States of America)
- Co-author(s): Sorayya, Aryo (HTD Biosystems Inc., Pleasanton, ca, United States of America)
Nayar, Rajiv (HTD Biosystems Inc., Pleasanton, ca, United States of America)
Currently, all vaccines in the market are freeze-sensitive and must be discarded upon freezing. Accidental freezing of vaccines is a global problem which results in millions of dollars in losses every year.
To test an adjuvant consisting of a specific lipid composition with varying surface charge for developing freeze-stable.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.